113 related articles for article (PubMed ID: 7752961)
1. M3-variant of acute promyelocytic leukaemia. A case report in a Malay boy.
Jazilah W; Ariffin W; Jackson N
Med J Malaysia; 1995 Mar; 50(1):105-7. PubMed ID: 7752961
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
Rodríguez Gómez M; López Fernández MF; Batlle J
Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
[TBL] [Abstract][Full Text] [Related]
3. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
Randolph TR
Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
[TBL] [Abstract][Full Text] [Related]
4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
5. Acute promyelocytic leukemia (AML-M3)--Part 1: Pathophysiology, clinical diagnosis, and differentiation therapy.
Randolph TR
Clin Lab Sci; 2000; 13(2):98-105. PubMed ID: 11066455
[TBL] [Abstract][Full Text] [Related]
6. Rare variant of acute promyelocytic leukaemia.
Mitra PK; Mukherjee C; Dasgupta A; Ghosh RN
J Indian Med Assoc; 1992 Sep; 90(9):245-6. PubMed ID: 1460318
[TBL] [Abstract][Full Text] [Related]
7. [M3 variant leukemia: clinical and diagnostic features].
Lusis MK; Machado C; Brito AE; Tabak D; de Oliveira MS
Rev Assoc Med Bras (1992); 1993; 39(4):224-8. PubMed ID: 8162087
[TBL] [Abstract][Full Text] [Related]
8. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.
Allford S; Grimwade D; Langabeer S; Duprez E; Saurin A; Chatters S; Walker H; Roberts P; Rogers J; Bain B; Patterson K; McKernan A; Freemont P; Solomon E; Burnett A; Goldstone A; Linch D
Br J Haematol; 1999 Apr; 105(1):198-207. PubMed ID: 10233384
[TBL] [Abstract][Full Text] [Related]
9. Correlation between morphological and cytochemical heterogeneity of acute promyelocytic leukemia (APL) and its association with myelodysplasia.
Varma N; Dash S; Sarode R
Indian J Cancer; 1990 Sep; 27(3):165-71. PubMed ID: 2090569
[TBL] [Abstract][Full Text] [Related]
10. [Acute renal failure in a patient with disseminated intravascular coagulation accompanied by acute promyelocytic leukemia: a case report, diagnostic difficulties].
Chudek J; Kopera M; Kokot F; Nieszporek T; Witkowicz J; Hołowiecki J
Przegl Lek; 2002; 59(1):61-2. PubMed ID: 12108050
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow necrosis obscuring the diagnosis of acute promyelocytic leukemia.
Wisecarver J; Harrington D
Hematol Pathol; 1988; 2(1):51-4. PubMed ID: 3235382
[TBL] [Abstract][Full Text] [Related]
12. Hand-mirror variant of microgranular acute promyelocytic leukemia.
Sun T; Weiss R
Leukemia; 1991 Mar; 5(3):266-9. PubMed ID: 2013982
[TBL] [Abstract][Full Text] [Related]
13. beta2 Integrins are characteristically absent in acute promyelocytic leukemia and rapidly upregulated in vivo upon differentiation with all-trans retinoic acid.
Wu JJ; Cantor A; Moscinski LC
Leuk Res; 2007 Jan; 31(1):49-57. PubMed ID: 16764927
[TBL] [Abstract][Full Text] [Related]
14. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of acute promyelocytic leukemia with disseminated intravascular coagulopathy: a case study.
Meriney DK
Oncol Nurs Forum; 1990; 17(3):379-83. PubMed ID: 2342971
[TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors.
Avvisati G; Lo Coco F; Mandelli F
Semin Hematol; 2001 Jan; 38(1):4-12. PubMed ID: 11172535
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of the AML-XH-99-M3 protocol for treatment of acute promyelocytic leukemia in children].
Chen J; Gu LJ; Tang JY; Xue HL; Pan C; Ye QD; Jiang H; Dong L; Zhou M; Wang YP
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):329-32. PubMed ID: 18554461
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.
Falanga A; Rickles FR
Best Pract Res Clin Haematol; 2003 Sep; 16(3):463-82. PubMed ID: 12935963
[TBL] [Abstract][Full Text] [Related]
19. Microgranular acute promyelocytic leukemia: a proposed role for a greater deformability of the leukemic cell.
Cantin G; Bernier V; Jacob S; Lyonnais J
Nouv Rev Fr Hematol (1978); 1989; 31(1):23-6. PubMed ID: 2915920
[TBL] [Abstract][Full Text] [Related]
20. AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes.
Haferlach T; Kohlmann A; Schnittger S; Dugas M; Hiddemann W; Kern W; Schoch C
Genes Chromosomes Cancer; 2005 Jun; 43(2):113-27. PubMed ID: 15751046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
